Log In
Print this Print this

Exviera, dasabuvir (ABT-333)

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNon-nucleoside HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV genotype 1 infection; Treat HCV genotype 1and 4 infection
Regulatory Designation

U.S. - Fast Track (Treat HCV genotype 1 infection);
EU - Standard Review (Treat HCV genotype 1 infection)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today